Your session is about to expire
← Back to Search
Primary Care Practices for Opioid Use Disorder (RISE-OK Trial)
RISE-OK Trial Summary
This trialaims to develop a program to help manage pain and opioid use disorder in elderly and vulnerable adults, using innovative solutions and evidence-based quality improvement methods.
RISE-OK Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RISE-OK Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Primary Care Practices
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants can potentially join this research project?
"Affirmative, the information available on clinicaltrials.gov denotes that this experiment is currently recruiting patients. It was first published on September 30th 2020 and most recently modified on November 21st 2022. The trial necessitates 1035 participants from a single site to be recruited."
What is the ultimate aim of this research endeavor?
"This trial has a duration of 17 months and its primary endpoint is the Morphine Milligram Equivalent (MME). Secondary endpoints include Chronic Opioid Therapy Statistics: Chronic pain Diagnosis, Diversification of Pain Therapy, and Pain-Function Interference which are expressed respectively as % of patients on chronic opioids with a chronic pain diagnosis; Number (and Type) of pharmacological and non-pharmacological treatment types; 3-item Pain-Enjoyment-General Activity (PEG) score."
Share this study with friends
Copy Link
Messenger